2018
DOI: 10.1055/s-0038-1677055
|View full text |Cite
|
Sign up to set email alerts
|

Pulmonary Arterial Hypertension and Pregnancy

Abstract: Pulmonary hypertension in pregnancy has always scared the treating physician and gynecologist due to reported high mortality since ages. The upcoming therapies targeting pulmonary hypertension (calcium channel blockers, nitric oxide, endothelin receptor antagonist, phosphodiesterase type 5 inhibitors) and improvement in hemodynamic monitoring and intensive management in pulmonary arterial hypertension (PAH) specialist centers give a ray of hope to these patients. Termination of pregnancy continues to be a mana… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 48 publications
0
1
0
Order By: Relevance
“…Hal ini memberikan 500 ml darah dari intervilli ke sirkulasi sentral (autotransfusi). 7,10 Perubahan kardiovaskular tetap terjadi hingga beberapa minggu setelah melahirkan. Curah jantung akan turun setelah 24 jam postpartum dan menjadi normal setelah 12-24 minggu postpartum.…”
Section: Perubahan Fisiologis Kardiovaskular Pada Kehamilanunclassified
“…Hal ini memberikan 500 ml darah dari intervilli ke sirkulasi sentral (autotransfusi). 7,10 Perubahan kardiovaskular tetap terjadi hingga beberapa minggu setelah melahirkan. Curah jantung akan turun setelah 24 jam postpartum dan menjadi normal setelah 12-24 minggu postpartum.…”
Section: Perubahan Fisiologis Kardiovaskular Pada Kehamilanunclassified
“…These clinics would cater to the needs of preconceptional risk assessment and counseling in patients with cardiac ailments, cardiovascular evaluation and diagnosis during pregnancy, diagnosis and treatment of pregnancy-associated hypertension and preeclampsia, management of native and prosthetic valvular disease, congenital heart disease (naive as well post procedural), cardiomyopathies (peripartum, dilated, and hypertrophic cardiomyopathy), and arrhythmias in pregnancy. [4][5][6][7][8][9][10][11] It would also review methods for fertility control for the patient with cardiac disease and the risk of cardiac drugs during pregnancy and lactation. Moreover, the diagnosis and management of acute catastrophies as deep vein thrombosis and pulmonary embolism during pregnancy, acute myocardial infarction, and spontaneous coronary dissection during pregnancy could have an active involvement of cardio-obstetrics team.…”
mentioning
confidence: 99%